The frequency of infectious illness deaths has increased public awareness of the risks associated with it and advanced worldwide research on antibiotics. Conversely, greater demand and usage of antibiotics is the cause of elevated antibiotic levels in natural ecosystems. Natural selection and adaptation resulted in gene changes that gave rise to antibiotic resistance in bacterial populations. The proliferation of antibiotic resistance genes in ecosystems led to the creation of antibiotic-resistant bacteria, which in turn led to the widespread rise of several antibiotic-resistant illnesses. The mechanisms that lead to cross-resistance to many medications (multidrug resistance), which is comparable to what is frequently observed in patients, have been uncovered. More recently, it has been shown that downstream genes, which are closely related to cell-cycle checkpoints, also seem to have a direct role in defining a patient's susceptibility to cytotoxic medications by controlling the cell's reaction to the damage caused by the drug. This review article examines a number of findings pertaining to the movement, persistence, and destiny of antibiotics as well as genes that cause antibiotic resistance in natural settings.